Back to Search
Start Over
Reported Xylazine Use Among Adults Aged [greater than or equal to] 18 Years Evaluated for Substance Use Treatment--United States, July 2022-September 2023
- Source :
- Morbidity and Mortality Weekly Report. July 4, 2024, Vol. 73 Issue 26, p594, 6 p.
- Publication Year :
- 2024
-
Abstract
- Introduction Xylazine, a nonopioid sedative, has been increasingly detected in illegally manufactured fentanyl (IMF) products* and in U.S. overdose deaths (1). Most detected xylazine-involved overdose deaths also involve IMF (2); [...]
Details
- Language :
- English
- ISSN :
- 01492195
- Volume :
- 73
- Issue :
- 26
- Database :
- Gale General OneFile
- Journal :
- Morbidity and Mortality Weekly Report
- Publication Type :
- News
- Accession number :
- edsgcl.801011372